PharmiWeb.com - Global Pharma News & Resources
14-Jan-2019

LOTEMAX Drug Profile, 2019 - ResearchAndMarkets.com

The "LOTEMAX Drug Profile, 2019" report has been added to ResearchAndMarkets.com's offering.

LOTEMAX Drug Profile, 2019 is part of a deep library of business intelligence on biopharmaceutical drugs.The report focuses on LOTEMAX and covers the following critical aspects of this drug:

  • United States patents
  • Expired United States patents
  • District Court patent litigation
  • Clinical trials
  • Drug prices
  • Annual sales revenues
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources

Topics Covered

  • Profile for LOTEMAX
  • US Regulatory Exclusivity
  • Expired US Patents
  • US District Court Litigation
  • Clinical Trials
  • Drug Prices - Average Pharmacy Cost
  • Drug Prices - Best Wholesale Price
  • Annual Sales Revenues
  • Finished Product Suppliers
  • Bulk API Sources

Companies Featured

  • Bausch & Lomb Incorporated
  • Pharmos
  • Novoseek
  • Molport
  • Abi Chem
  • Akos Consulting & Solutions
  • Chemmol
  • Abblis Chemicals
  • Medchemexpress Mce
  • Abachemscene
  • Chembase.Cn
  • Ak Scientific Inc. (Aksci)
  • Syntree
  • Avachem Scientific
  • Race Chemical
  • Ahh Chemical Co. Ltd
  • Boc Sciences
  • Zinc
  • Molcore
  • Aurora Fine Chemicals Llc
  • Key Organics/Bionet
  • Apexbio Technology
  • Chem-Space.Com Database
  • Enovation Chemicals
  • Labnetwork
  • A Wuxi Apptec Company
  • Alfa Chemistry
  • Selleckchem
  • Chemieliva Pharmaceutical Co. Ltd
  • Dc Chemicals
  • Musechem
  • Biochempartner
  • Hairui Chemical
  • 001Chemical
  • and many more...

For more information about this report visit https://www.researchandmarkets.com/research/9ksqgp/lotemax_drug?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20190114005398/en/

Editor Details

Last Updated: 14-Jan-2019